BioNTech durchläuft die turbulenteste Woche ihrer jüngeren Unternehmensgeschichte. Am Dienstag kappte der Mainzer Biotechkonzern seine Umsatzprognose für 2026 deutlich, tags darauf verkündete der ...
Arbutus Biopharma and its licensee Genevant filed three patent infringement lawsuits against Pfizer and BioNTech for its lipid nanoparticle technology. The clinical-stage biopharmaceutical company is ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Bucks County-based Arbutus also ...
Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid nanoparticle (“LNP”) technology against Pfizer and ...
As Pfizer and Moderna have tied off certain threads in their separate webs of mRNA patent litigation, Sanofi has opened a new front to challenge the companies’ blockbuster COVID-19 vaccines. In ...
The cases add to a web of high-stakes patent lawsuits filed by biotech companies against Pfizer and Moderna over the mRNA technology used in their COVID vaccines. Spokespeople for Pfizer and Moderna ...
Hosted on MSN
Pfizer, BioNTech face global patent suits from Arbutus, Roivant over COVID vaccine tech
Arbutus Biopharma (ABUS) and Genevant Sciences, a subsidiary of Roivant Sciences (ROIV), on Thursday announced the filing of three international lawsuits over a patent dispute related to Pfizer (PFE) ...
Biontech war in der Corona-Zeit eine Goldgrube, heute verbrennt das Unternehmen Geld. Der Verlust belief sich im ersten ...
In 2025, Pfizer paid roughly $9.8 billion in dividends. Through the first half of 2026, it paid roughly $4.8 billion. That's a total of $14.6 billion in dividends over the last six quarters. It is a ...
July 22 (Reuters) - Pfizer (PFE.N), opens new tab said on Wednesday the U.S. Food and Drug Administration had granted priority review to its application seeking expanded approval for its prostate ...
Following the near collapse of the Pfizer building conversion project last week, the industry has grappled with the potential impacts of the alarming structural failure. Aside from the consequences ...
A week after a safety incident made national news, we’re beginning to get clarity on what led to a blocks-wide evacuation at the project at the former Pfizer Building. It appears that construction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results